Vivani Medical, Inc. (VANI)
Data as of , from SEC Form 4 filings.
See up to 3 months of VANI. The 7-day demo opens the 1M and 3M ranges and puts VANI on your watchlist.
Start 7-day demoLatest VANI insider trades
About Vivani Medical, Inc. (VANI)
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
- ALAMEDA, CA
- 36
- 2022
- XNAS
VANI Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 11 | 885,465 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
VANI insider transactions (Form 4)
3447 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Alexandra L. Popoff - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 35,135 | $1.27 | $45K | |
| Daniel Bradbury - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 35,135 | $1.27 | $45K | |
| Daniel Bradbury - Director | Derivative | Non-Qualified Stock Option (right to buy) | 237 | $1.16 | $275 | |
| Anthony Baldor - Officer | Grant or award | Common Stock Option | 600,000 | $0.00 | - | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 3,499 | $1.01 | $4K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 6,836 | $1.01 | $7K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 2,405 | $1.01 | $2K | |
| Donald Dwyer - Officer | Grant or award | Common Stock Option | 70,000 | $0.00 | - | |
| Donald Dwyer - Officer | Grant or award | RSUs | 35,000 | $0.00 | - | |
| Brigid Makes - Officer | Grant or award | Common Stock Option | 75,000 | $0.00 | - | |
| Brigid Makes - Officer | Grant or award | RSUs | 37,500 | $0.00 | - | |
| Truc le - Officer | Grant or award | Common Stock Option | 160,000 | $0.00 | - | |
| Truc le - Officer | Grant or award | RSUs | 80,000 | $0.00 | - | |
| Lisa Ellen Porter - Officer | Grant or award | Common Stock Option | 80,000 | $0.00 | - | |
| Lisa Ellen Porter - Officer | Grant or award | RSUs | 40,000 | $0.00 | - | |
| Adam Mendelsohn - Officer | Grant or award | Common Stock Option | 200,000 | $0.00 | - | |
| Adam Mendelsohn - Officer | Grant or award | RSUs | 100,000 | $0.00 | - | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 1,113 | $1.01 | $1K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 1,569 | $1.01 | $2K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 243 | $1.01 | $245 | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 18,529 | $1.02 | $19K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 2,311 | $1.01 | $2K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 34,000 | $0.99 | $34K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 44,400 | $0.99 | $44K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 5,600 | $0.98 | $5K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 58,583 | $0.99 | $58K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 62,899 | $1.02 | $64K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 2,000 | $1.01 | $2K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 22,939 | $1.00 | $23K | |
| Donald Dwyer - Officer | Open-market purchase | Common Stock | 4,000 | $1.03 | $4K | |
| Gregg Williams - Director | Open-market purchase | Common Stock | 3,968,253 | $1.26 | $5.00M | |
| Donald Dwyer - Officer | Open-market purchase | Common Stock | 1,000 | $1.14 | $1K | |
| Donald Dwyer - Officer | Open-market purchase | Common Stock | 1,000 | $1.13 | $1K | |
| Donald Dwyer - Officer | Open-market purchase | Common Stock | 500 | $1.13 | $565 |
VANI insider trading FAQ
What is the latest insider trade for VANI?
Vivani Medical, Inc. (VANI) had 6 insider filings in the last 90 days, with the most recent on 2026-07-31. The full record for VANI runs to 47 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VANI stock?
No insider purchases of VANI were filed in the last 90 days. 41 purchases are on record for this company.
How many insiders are selling VANI stock?
No insider sales of VANI were filed in the last 90 days.
Where can I see VANI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VANI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Donald Dwyer view on EDGAR
- - Lisa Ellen Porter view on EDGAR
- - Anthony Baldor view on EDGAR
- - Truc le view on EDGAR
- - Adam Mendelsohn view on EDGAR
- - Daniel Bradbury view on EDGAR
- - Gregg Williams view on EDGAR
- - August J. Moretti view on EDGAR
- - Gregg Williams view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where VANI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VANI with a 7-day demo
- VANI on your watchlist
- Every VANI Form 4 filing on record
- Up to 3 months of VANI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
